Worldwide prevalence of head lice.

Comparative in vitro tests on the efficacy and safety of 13 anti-head-lice products. Parasitol Res (2009) 1.43

Pediculosis capitis: new insights into epidemiology, diagnosis and treatment. Eur J Clin Microbiol Infect Dis (2012) 1.26

Efficacy of a single treatment of head lice with a neem seed extract: an in vivo and in vitro study on nits and motile stages. Parasitol Res (2011) 1.24

Comparative efficacy of new commercial pediculicides against adults and eggs of Pediculus humanus capitis (head lice). Parasitol Res (2011) 1.12

Research and increase of expertise in arachno-entomology are urgently needed. Parasitol Res (2011) 1.01

A new two-phase dimeticone pediculicide shows high efficacy in a comparative bioassay. BMC Dermatol (2009) 0.98

Socioeconomic status, family background and other key factors influence the management of head lice in Norway. Parasitol Res (2014) 0.97

Eucalyptus essential oil toxicity against permethrin-resistant Pediculus humanus capitis (Phthiraptera: Pediculidae). Parasitol Res (2009) 0.94

Head lice prevalence among households in Norway: importance of spatial variables and individual and household characteristics. Parasitology (2011) 0.94

Participation of women and sex analyses in late-phase clinical trials of new molecular entity drugs and biologics approved by the FDA in 2007-2009. J Womens Health (Larchmt) (2013) 0.91

Bioactivity of Argentinean essential oils against permethrin-resistant head lice, Pediculus humanus capitis. J Insect Sci (2010) 0.89

Ex vivo effectiveness of French over-the-counter products against head lice (Pediculus humanus capitis De Geer, 1778). Parasitol Res (2015) 0.89

Efficacy of a grapefruit extract on head lice: a clinical trial. Parasitol Res (2009) 0.87

Head lice in Norwegian households: actions taken, costs and knowledge. PLoS One (2012) 0.87

In vitro pediculicidal activity of herbal shampoo base on Thai local plants against head louse (Pediculus humanus capitis De Geer). Parasitol Res (2013) 0.85

Designing randomized-controlled trials to improve head-louse treatment: systematic review using a vignette-based method. J Invest Dermatol (2013) 0.82

Efficacy of herbal shampoo base on native plant against head lice (Pediculus humanus capitis De Geer, Pediculidae: Phthiraptera) in vitro and in vivo in Thailand. Parasitol Res (2014) 0.82

Epidemiology of pediculosis capitis among schoolchildren in the eastern area of Bangkok, Thailand. Asian Pac J Trop Biomed (2012) 0.82

High diversity and rapid diversification in the head louse, Pediculus humanus (Pediculidae: Phthiraptera). Sci Rep (2015) 0.81

Of lice and math: using models to understand and control populations of head lice. PLoS One (2011) 0.81

The biology and taxonomy of head and body lice--implications for louse-borne disease prevention. PLoS Pathog (2013) 0.80

Efficacy and Safety of a Mineral Oil-Based Head Lice Shampoo: A Randomized, Controlled, Investigator-Blinded, Comparative Study. PLoS One (2016) 0.80

Head louse control by suffocation due to blocking their oxygen uptake. Parasitol Res (2015) 0.79

Chemical composition and efficacy of some selected plant oils against Pediculus humanus capitis in vitro. Parasitol Res (2016) 0.77

Impact of family ownerships, individual hygiene, and residential environments on the prevalence of pediculosis capitis among schoolchildren in urban and rural areas of northwest of Iran. Parasitol Res (2015) 0.77

Head lice predictors and infestation dynamics among primary school children in Norway. Fam Pract (2015) 0.76

Prevalence and risk factors associated with pediculosis capitis in an impoverished urban community in lima, peru. J Glob Infect Dis (2013) 0.76

Head Lice. Dtsch Arztebl Int (2016) 0.75

A systematic literature review of pediculosis due to head lice in the Pacific Island Countries and Territories: what country specific research on head lice is needed? BMC Dermatol (2014) 0.75

HEAD LICE IN HAIR SAMPLES FROM YOUTHS, ADULTS AND THE ELDERLY IN MANAUS, AMAZONAS STATE, BRAZIL. Rev Inst Med Trop Sao Paulo (2015) 0.75

The louse is (no longer) in the house. Can Fam Physician (2016) 0.75

Human pathogens in body and head lice. Emerg Infect Dis (2002) 1.89

Parasitic skin diseases: health care-seeking in a slum in north-east Brazil. Trop Med Int Health (2003) 1.47

Rural life, lower socioeconomic status and parasitic infections. Parasitol Int (2007) 1.42

What parents in Australia know and do about head lice. Rural Remote Health (2007) 1.14

A stochastic model for head lice infections. J Math Biol (2007) 1.10

Incidence and prevalence of head lice in a district health authority area. Commun Dis Public Health (2003) 1.05

Head louse infestations: the "no nit" policy and its consequences. Int J Dermatol (2006) 0.98

Lice infestation and lice control remedies in the Ukraine. Ann N Y Acad Sci (2006) 0.91

Prevalence and monthly distribution of head lice using two diagnostic procedures in several age groups in Uberlândia, State of Minas Gerais, Southeastern Brazil. Rev Soc Bras Med Trop (2007) 0.91

Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J (2007) 7.45

A bibliometric analysis of global research production in respiratory medicine. Chest (2005) 4.15

Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J (2008) 3.60

Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med (2010) 3.43

Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol (2009) 3.27

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis (2008) 2.87

All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol (2011) 2.80

Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. J Antimicrob Chemother (2007) 2.79

Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med (2007) 2.58

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother (2005) 2.47

Comparison of amount of biomedical research originating from the European Union and the United States. BMJ (2005) 2.42

Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect (2009) 2.40

Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol (2007) 2.35

Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. Chest (2013) 2.32

Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis (2014) 2.29

Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg (2008) 2.10

Fosfomycin: use beyond urinary tract and gastrointestinal infections. Clin Infect Dis (2008) 2.08

β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis (2011) 2.03

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother (2012) 2.01

Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother (2008) 1.98

Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis (2008) 1.91

Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother (2007) 1.89

Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials. Lancet Infect Dis (2005) 1.89

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents (2009) 1.88

Estimates of global production in cardiovascular diseases research. Int J Cardiol (2005) 1.87

Statins for infection and sepsis: a systematic review of the clinical evidence. J Antimicrob Chemother (2008) 1.85

Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother (2013) 1.85

Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? J Infect (2012) 1.84

The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. J Antimicrob Chemother (2006) 1.80

Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol (2008) 1.77

Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. PLoS Negl Trop Dis (2008) 1.75

Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis (2005) 1.74

Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother (2008) 1.73

Unique author identification number in scientific databases: a suggestion. PLoS Med (2006) 1.73

Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol (2010) 1.70

The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol (2009) 1.70

Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med (2008) 1.69

Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: systematic review and meta-analysis. Respir Med (2010) 1.67

Resistance to polymyxins: Mechanisms, frequency and treatment options. Drug Resist Updat (2010) 1.66

The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res (2007) 1.65

STING Millennium: A web-based suite of programs for comprehensive and simultaneous analysis of protein structure and sequence. Nucleic Acids Res (2003) 1.64

Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. Br J Haematol (2005) 1.60

Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ (2008) 1.60

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care (2005) 1.58

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother (2008) 1.56

Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J Antimicrob Chemother (2011) 1.55

Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials. Chest (2007) 1.55

Impact of patient position on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. J Crit Care (2009) 1.55

Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann Intensive Care (2011) 1.54

Research contribution of different world regions in the top 50 biomedical journals (1995-2002). FASEB J (2006) 1.54

Prevalence of hepatitis B, hepatitis C, and HIV infections among patients in a psychiatric hospital in Greece. Psychiatr Serv (2009) 1.54

Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis (2006) 1.52

Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care (2007) 1.52

Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. CMAJ (2008) 1.51

Impact of passive humidification on clinical outcomes of mechanically ventilated patients: a meta-analysis of randomized controlled trials. Crit Care Med (2007) 1.50

Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: a meta-analysis of randomized controlled trials. Am Heart J (2007) 1.49

It's all in the face: amiodarone-induced myxedema and skin pigmentation. Eur J Dermatol (2006) 1.47

New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis (2008) 1.45

Bowel cleansing before bowel surgery: major discordance between evidence and practice. J Gastrointest Surg (2008) 1.45

Do we still need the aminoglycosides? Int J Antimicrob Agents (2008) 1.45

World databases of summaries of articles in the biomedical fields. Arch Intern Med (2007) 1.43

Effectiveness and safety of short-course vs long-course antibiotic therapy for group a beta hemolytic streptococcal tonsillopharyngitis: a meta-analysis of randomized trials. Mayo Clin Proc (2008) 1.42

Non-physicians may reach correct diagnoses by using Google: a pilot study. Swiss Med Wkly (2008) 1.40

Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials. Spine (Phila Pa 1976) (2008) 1.40

Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother (2006) 1.39

Worldwide trends in quantity and quality of published articles in the field of infectious diseases. BMC Infect Dis (2005) 1.39

From conference abstract to full paper: differences between data presented in conferences and journals. FASEB J (2005) 1.39

Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob Agents Chemother (2009) 1.38

Pain and a purple lesion. Am J Med (2006) 1.38

Infectious disease cases for educational purposes: open-access resources on the Internet. Clin Infect Dis (2007) 1.38

Tuberculosis of the oral cavity: a systematic review. Eur J Oral Sci (2010) 1.37

Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents (2008) 1.36

Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. Int J Antimicrob Agents (2009) 1.35

Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol (2009) 1.34

Polymyxin B: similarities to and differences from colistin (polymyxin E). Expert Rev Anti Infect Ther (2007) 1.34

A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol (2010) 1.34

Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin. Scand J Infect Dis (2005) 1.33

Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS One (2011) 1.33

Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents (2012) 1.32

Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology (2008) 1.30

Human infections associated with wild birds. J Infect (2007) 1.29

An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis (2008) 1.29

A bibliometric analysis in the fields of preventive medicine, occupational and environmental medicine, epidemiology, and public health. BMC Public Health (2006) 1.27

Mapping health literacy research in the European Union: a bibliometric analysis. PLoS One (2008) 1.25